Bio­gen’s R&D prun­ing hits dig­i­tal health as biotech scraps 23,000-per­son cog­ni­tive study with Ap­ple

Bio­gen axed its 23,000-per­son cog­ni­tive health study with Ap­ple phones and watch­es last week as part of a broad­er pull­back in the biotech’s fledg­ling dig­i­tal health unit, per an up­date to a US fed­er­al tri­als data­base.

Just two years in­to its dig­i­tal health ex­pan­sion, Bio­gen is cut­ting back, per a STAT News re­port from Wednes­day cit­ing Bio­gen cor­po­rate de­vel­op­ment leader Adam Keeney. The move comes as Bio­gen’s new lead­er­ship con­sol­i­dates its pipeline, re­moves 1,000 po­si­tions and di­gests its first ac­qui­si­tion in four years.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER